Company profile for Cue Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without the need for ex vi...
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without the need for ex vivo manipulation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
21 Erie Street Cambridge, MA 02139
Telephone
Telephone
617-949-2680
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/19/3208453/0/en/Cue-Biopharma-Announces-Pricing-of-10-Million-Public-Offering.html

GLOBENEWSWIRE
19 Dec 2025

https://www.businesswire.com/news/home/20251113268855/en/Singapore-based-ImmunoScape-Pioneers-Next-Generation-Cell-Therapy-for-Solid-Tumors-Announces-Key-Licensing-Deal-New-Board-and-SAB-Appointments

BUSINESSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186774/0/en/Cue-Biopharma-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182503/0/en/Cue-Biopharma-and-ImmunoScape-Announce-Strategic-Collaboration-to-Develop-Breakthrough-Cell-Therapy-Approach-for-Solid-Tumors.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/09/29/3157785/0/en/Cue-Biopharma-Announces-Strategic-Transition-in-Leadership-to-Further-Enable-Next-Stage-of-Growth-with-Disruptive-Autoimmune-Therapeutic-Candidates.html

GLOBENEWSWIRE
29 Sep 2025

https://www.globenewswire.com/news-release/2025/08/21/3137060/0/en/Cue-Biopharma-to-Participate-in-Fireside-Chat-at-the-Cantor-Global-Healthcare-Conference.html

GLOBENEWSWIRE
21 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty